Zdrowie i gospodarka · 14/11/2018

FDA Announces Final Guidance for Residue Studies in Honey for Veterinary Medicinal Products

The US Food and Drug Administration (FDA) has released a final guidance document (GFI #243) for the industry, outlining study design recommendations for evaluating the metabolism and residue kinetics of veterinary drugs in honey, with the goal of establishing safe maximum residue limits (MRLs) and withdrawal periods for veterinary medicinal products treated with these drugs.